位置:首页 > 蛋白库 > KIT_MOUSE
KIT_MOUSE
ID   KIT_MOUSE               Reviewed;         979 AA.
AC   P05532; Q61415; Q61416; Q61417; Q6LEE9; Q6QJB7; Q6QJB8; Q7TS86; Q8C8K9;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   19-OCT-2011, sequence version 3.
DT   03-AUG-2022, entry version 223.
DE   RecName: Full=Mast/stem cell growth factor receptor Kit;
DE            Short=SCFR;
DE            EC=2.7.10.1;
DE   AltName: Full=Proto-oncogene c-Kit;
DE   AltName: Full=Tyrosine-protein kinase Kit;
DE   AltName: CD_antigen=CD117;
DE   Flags: Precursor;
GN   Name=Kit; Synonyms=Sl;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT GLU-207.
RC   STRAIN=BALB/cJ; TISSUE=Brain;
RX   PubMed=2456920; DOI=10.1002/j.1460-2075.1988.tb02907.x;
RA   Qiu F., Ray P., Brown K., Barker P.E., Jhanwar S., Ruddle F.H., Besmer P.;
RT   "Primary structure of c-kit: relationship with the CSF-1/PDGF receptor
RT   kinase family -- oncogenic activation of v-kit involves deletion of
RT   extracellular domain and C-terminus.";
RL   EMBO J. 7:1003-1011(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J; TISSUE=Medulla oblongata;
RX   PubMed=1709486; DOI=10.1093/nar/19.6.1267;
RA   Hayashi S., Kunisada T., Ogawa M., Yamaguchi K., Nishikawa S.;
RT   "Exon skipping by mutation of an authentic splice site of c-kit gene in W/W
RT   mouse.";
RL   Nucleic Acids Res. 19:1267-1271(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 3), AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=ICR;
RX   PubMed=1378413; DOI=10.1016/0012-1606(92)90172-d;
RA   Rossi P., Marziali G., Albanesi C., Charlesworth A., Geremia R.,
RA   Sorrentino V.;
RT   "A novel c-kit transcript, potentially encoding a truncated receptor,
RT   originates within a kit gene intron in mouse spermatids.";
RL   Dev. Biol. 152:203-207(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND MUTAGENESIS OF PHE-860.
RC   STRAIN=C57BL/6J;
RX   PubMed=15731517; DOI=10.1534/genetics.104.027177;
RA   Ruan H.B., Zhang N., Gao X.;
RT   "Identification of a novel point mutation of mouse proto-oncogene c-kit
RT   through N-ethyl-N-nitrosourea mutagenesis.";
RL   Genetics 169:819-831(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=C57BL/6J, and FVB/N; TISSUE=Brain, and Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-22.
RC   STRAIN=BALB/cJ;
RX   PubMed=7682073; DOI=10.1006/bbrc.1993.1301;
RA   Yasuda H., Galli S.J., Geissler E.N.;
RT   "Cloning and functional analysis of the mouse c-kit promoter.";
RL   Biochem. Biophys. Res. Commun. 191:893-901(1993).
RN   [8]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=1698611; DOI=10.1002/j.1460-2075.1990.tb07528.x;
RA   Tan J.C., Buck J., Levi E., Besmer P.;
RT   "Candidate ligand for the c-kit transmembrane kinase receptor: KL, a
RT   fibroblast derived growth factor stimulates mast cells and erythroid
RT   progenitors.";
RL   EMBO J. 9:3287-3294(1990).
RN   [9]
RP   FUNCTION IN ACTIVATION OF PLCG1, INTERACTION WITH PLCG1, ALTERNATIVE
RP   SPLICING, PHOSPHORYLATION, GLYCOSYLATION, AND CHARACTERIZATION OF VARIANTS
RP   W37 LYS-586 AND W41 MET-835.
RX   PubMed=1714377; DOI=10.1002/j.1460-2075.1991.tb07784.x;
RA   Reith A.D., Ellis C., Lyman S.D., Anderson D.M., Williams D.E.,
RA   Bernstein A., Pawson T.;
RT   "Signal transduction by normal isoforms and W mutant variants of the Kit
RT   receptor tyrosine kinase.";
RL   EMBO J. 10:2451-2459(1991).
RN   [10]
RP   INTERACTION WITH PIK3R1, AND FUNCTION IN PHOSPHORYLATION OF PIK3R1.
RX   PubMed=7509796; DOI=10.1016/s0021-9258(17)37564-6;
RA   Serve H., Hsu Y.C., Besmer P.;
RT   "Tyrosine residue 719 of the c-kit receptor is essential for binding of the
RT   P85 subunit of phosphatidylinositol (PI) 3-kinase and for c-kit-associated
RT   PI 3-kinase activity in COS-1 cells.";
RL   J. Biol. Chem. 269:6026-6030(1994).
RN   [11]
RP   UBIQUITINATION, SUBCELLULAR LOCATION, CATALYTIC ACTIVITY, PHOSPHORYLATION
RP   AT TYR-825, INTERACTION WITH PIK3R1, CHARACTERIZATION OF VARIANT W42
RP   ASN-794, MUTAGENESIS OF TYR-723, AND TISSUE SPECIFICITY.
RX   PubMed=7527401; DOI=10.1016/s0021-9258(18)31793-9;
RA   Yee N.S., Hsiau C.W., Serve H., Vosseller K., Besmer P.;
RT   "Mechanism of down-regulation of c-kit receptor. Roles of receptor tyrosine
RT   kinase, phosphatidylinositol 3'-kinase, and protein kinase C.";
RL   J. Biol. Chem. 269:31991-31998(1994).
RN   [12]
RP   ALTERNATIVE SPLICING, AND FUNCTION IN ACTIVATION OF PLCG1.
RX   PubMed=9722617; DOI=10.1083/jcb.142.4.1063;
RA   Sette C., Bevilacqua A., Geremia R., Rossi P.;
RT   "Involvement of phospholipase Cgamma1 in mouse egg activation induced by a
RT   truncated form of the C-kit tyrosine kinase present in spermatozoa.";
RL   J. Cell Biol. 142:1063-1074(1998).
RN   [13]
RP   INTERACTION WITH PTPN6/SHP-1 AND PTPN11/SHP-2, FUNCTION IN PHOSPHORYLATION
RP   OF PTPN6/SHP-1, AND MUTAGENESIS OF TYR-571 AND TYR-573.
RX   PubMed=9528781; DOI=10.1128/mcb.18.4.2089;
RA   Kozlowski M., Larose L., Lee F., Le D.M., Rottapel R., Siminovitch K.A.;
RT   "SHP-1 binds and negatively modulates the c-Kit receptor by interaction
RT   with tyrosine 569 in the c-Kit juxtamembrane domain.";
RL   Mol. Cell. Biol. 18:2089-2099(1998).
RN   [14]
RP   REVIEW ON ROLE IN SPERMATOGENESIS AND FERTILITY.
RX   PubMed=12558531; DOI=10.1046/j.1439-0272.2003.00539.x;
RA   Rossi P., Dolci S., Sette C., Geremia R.;
RT   "Molecular mechanisms utilized by alternative c-kit gene products in the
RT   control of spermatogonial proliferation and sperm-mediated egg
RT   activation.";
RL   Andrologia 35:71-78(2003).
RN   [15]
RP   INTERACTION WITH FES/FPS.
RX   PubMed=17595334; DOI=10.1182/blood-2007-02-076471;
RA   Voisset E., Lopez S., Dubreuil P., De Sepulveda P.;
RT   "The tyrosine kinase FES is an essential effector of KITD816V proliferation
RT   signal.";
RL   Blood 110:2593-2599(2007).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-571; TYR-573; TYR-706 AND
RP   TYR-938, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Mast cell;
RX   PubMed=17947660; DOI=10.4049/jimmunol.179.9.5864;
RA   Cao L., Yu K., Banh C., Nguyen V., Ritz A., Raphael B.J., Kawakami Y.,
RA   Kawakami T., Salomon A.R.;
RT   "Quantitative time-resolved phosphoproteomic analysis of mast cell
RT   signaling.";
RL   J. Immunol. 179:5864-5876(2007).
RN   [17]
RP   FUNCTION IN MAST CELL MIGRATION, AND IN SIGNALING VIA FYN.
RX   PubMed=18725415; DOI=10.1074/jbc.m804077200;
RA   Samayawardhena L.A., Pallen C.J.;
RT   "Protein-tyrosine phosphatase alpha regulates stem cell factor-dependent c-
RT   Kit activation and migration of mast cells.";
RL   J. Biol. Chem. 283:29175-29185(2008).
RN   [18]
RP   ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=18447649; DOI=10.1089/scd.2007.0101;
RA   Zayas J., Spassov D.S., Nachtman R.G., Jurecic R.;
RT   "Murine hematopoietic stem cells and multipotent progenitors express
RT   truncated intracellular form of c-kit receptor.";
RL   Stem Cells Dev. 17:343-353(2008).
RN   [19]
RP   FUNCTION IN MAST CELL DEGRANULATION.
RX   PubMed=21037083; DOI=10.2353/ajpath.2010.100369;
RA   Chen S., Burgin S., McDaniel A., Li X., Yuan J., Chen M., Khalaf W.,
RA   Clapp D.W., Yang F.C.;
RT   "Nf1-/- Schwann cell-conditioned medium modulates mast cell degranulation
RT   by c-Kit-mediated hyperactivation of phosphatidylinositol 3-kinase.";
RL   Am. J. Pathol. 177:3125-3132(2010).
RN   [20]
RP   INTERACTION WITH IL1RL1 AND IL1RAP, AND SUBUNIT.
RX   PubMed=20200353; DOI=10.1182/blood-2009-10-247411;
RA   Drube S., Heink S., Walter S., Loehn T., Grusser M., Gerbaulet A.,
RA   Berod L., Schons J., Dudeck A., Freitag J., Grotha S., Reich D.,
RA   Rudeschko O., Norgauer J., Hartmann K., Roers A., Kamradt T.;
RT   "The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in
RT   mast cells.";
RL   Blood 115:3899-3906(2010).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-720, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Lung, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [22]
RP   VARIANT GLU-207.
RA   Jawad-Alam J.;
RL   Unpublished observations (APR-2010).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 25-314 IN COMPLEX WITH KITLG/SCF,
RP   DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-296 AND ASN-303.
RX   PubMed=17255936; DOI=10.1038/sj.emboj.7601545;
RA   Liu H., Chen X., Focia P.J., He X.;
RT   "Structural basis for stem cell factor-KIT signaling and activation of
RT   class III receptor tyrosine kinases.";
RL   EMBO J. 26:891-901(2007).
RN   [24]
RP   VARIANT W42 ASN-794.
RX   PubMed=1688471; DOI=10.1126/science.1688471;
RA   Tan J.C., Nocka K., Ray P., Traktman P., Besmer P.;
RT   "The dominant W42 spotting phenotype results from a missense mutation in
RT   the c-kit receptor kinase.";
RL   Science 247:209-212(1990).
RN   [25]
RP   VARIANTS W37 LYS-586; WV MET-664 AND W41 MET-835.
RX   PubMed=1693331; DOI=10.1002/j.1460-2075.1990.tb08305.x;
RA   Nocka K., Tan J.C., Chiu E., Chu T.Y., Ray P., Traktman P., Besmer P.;
RT   "Molecular bases of dominant negative and loss of function mutations at the
RT   murine c-kit/white spotting locus: W37, Wv, W41 and W.";
RL   EMBO J. 9:1805-1813(1990).
CC   -!- FUNCTION: Tyrosine-protein kinase that acts as cell-surface receptor
CC       for the cytokine KITLG/SCF and plays an essential role in the
CC       regulation of cell survival and proliferation, hematopoiesis, stem cell
CC       maintenance, gametogenesis, mast cell development, migration and
CC       function, and in melanogenesis. In response to KITLG/SCF binding, KIT
CC       can activate several signaling pathways. Phosphorylates PIK3R1, PLCG1,
CC       SH2B2/APS and CBL. Activates the AKT1 signaling pathway by
CC       phosphorylation of PIK3R1, the regulatory subunit of
CC       phosphatidylinositol 3-kinase. Activated KIT also transmits signals via
CC       GRB2 and activation of RAS, RAF1 and the MAP kinases MAPK1/ERK2 and/or
CC       MAPK3/ERK1. Promotes activation of STAT family members STAT1, STAT3,
CC       STAT5A and STAT5B. Activation of PLCG1 leads to the production of the
CC       cellular signaling molecules diacylglycerol and inositol 1,4,5-
CC       trisphosphate. KIT signaling is modulated by protein phosphatases, and
CC       by rapid internalization and degradation of the receptor. Activated KIT
CC       promotes phosphorylation of the protein phosphatases PTPN6/SHP-1 and
CC       PTPRU, and of the transcription factors STAT1, STAT3, STAT5A and
CC       STAT5B. Promotes phosphorylation of PIK3R1, CBL, CRK (isoform Crk-II),
CC       LYN, MAPK1/ERK2 and/or MAPK3/ERK1, PLCG1, SRC and SHC1.
CC       {ECO:0000269|PubMed:1698611, ECO:0000269|PubMed:1714377,
CC       ECO:0000269|PubMed:18725415, ECO:0000269|PubMed:21037083,
CC       ECO:0000269|PubMed:7509796, ECO:0000269|PubMed:9528781,
CC       ECO:0000269|PubMed:9722617}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028,
CC         ECO:0000269|PubMed:7527401};
CC   -!- ACTIVITY REGULATION: Present in an inactive conformation in the absence
CC       of bound ligand. KITLG/SCF binding leads to dimerization and activation
CC       by autophosphorylation.
CC   -!- SUBUNIT: Monomer in the absence of bound KITLG/SCF. Homodimer in the
CC       presence of bound KITLG/SCF, forming a heterotetramer with two
CC       KITLG/SCF molecules. Interacts (via phosphorylated tyrosine residues)
CC       with the adapter proteins GRB2 and GRB7 (via SH2 domain), and
CC       SH2B2/APS. Interacts (via C-terminus) with MPDZ (via the tenth PDZ
CC       domain). Interacts (via phosphorylated tyrosine residues) with the
CC       protein phosphatases PTPN6/SHP-1 (via SH2 domain), PTPN11/SHP-2 (via
CC       SH2 domain) and PTPRU. Interacts with DOK1 and TEC (By similarity).
CC       Interacts with the protein kinase FES/FPS. Interacts with PLCG1.
CC       Interacts (via phosphorylated tyrosine residues) with PIK3R1 and PIK3
CC       catalytic subunit. Interacts (KITLG/SCF-bound) with IL1RL1. Interacts
CC       with IL1RAP (independent of stimulation with KITLG/SCF). A mast cell-
CC       specific KITLG/SCF-induced interleukin-33 signaling complex contains
CC       IL1RL1, IL1RAP, KIT and MYD88. {ECO:0000250|UniProtKB:P10721,
CC       ECO:0000269|PubMed:1698611, ECO:0000269|PubMed:1714377,
CC       ECO:0000269|PubMed:17255936, ECO:0000269|PubMed:17595334,
CC       ECO:0000269|PubMed:20200353, ECO:0000269|PubMed:7509796,
CC       ECO:0000269|PubMed:7527401, ECO:0000269|PubMed:9528781}.
CC   -!- INTERACTION:
CC       P05532; P26955: Csf2rb; NbExp=4; IntAct=EBI-8559255, EBI-1810026;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane; Single-pass type I
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cell membrane; Single-pass type I
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Cytoplasm. Note=Detected in the
CC       cytoplasm of spermatozoa, especially in the equatorial and subacrosomal
CC       region of the sperm head. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=GNNK(+), KitA(+);
CC         IsoId=P05532-1; Sequence=Displayed;
CC       Name=2; Synonyms=GNNK(-), Kit(+);
CC         IsoId=P05532-2; Sequence=VSP_041870;
CC       Name=3; Synonyms=Tr-kit, Truncated;
CC         IsoId=P05532-3; Sequence=VSP_041868, VSP_041869;
CC   -!- TISSUE SPECIFICITY: Isoform 1 and isoform 2 are detected in bone marrow
CC       cells, spermatogonia and spermatocytes, but not in round spermatids,
CC       elongating spermatids and spermatozoa. Isoform 3 is detected in round
CC       spermatids, elongating spermatids and spermatozoa, but not in
CC       spermatogonia and spermatocytes (at protein level). Isoform 1 is widely
CC       expressed and detected in fetal liver and bone marrow. Isoform 3 is
CC       detected in bone marrow cells enriched in hematopoietic stem cells.
CC       {ECO:0000269|PubMed:1378413, ECO:0000269|PubMed:18447649,
CC       ECO:0000269|PubMed:7527401}.
CC   -!- PTM: Ubiquitinated by SOCS6. KIT is rapidly ubiquitinated after
CC       autophosphorylation induced by KITLG/SCF binding, leading to
CC       internalization and degradation (By similarity). {ECO:0000250}.
CC   -!- PTM: Autophosphorylated on tyrosine residues. KITLG/SCF binding
CC       promotes autophosphorylation of isoform 1 and isoform 2. Isoform 1
CC       shows low levels of tyrosine phosphorylation in the absence of added
CC       KITLG/SCF, while isoform 2 requires stimulation by KITLG/SCF for
CC       phosphorylation (in vitro). Phosphorylation of Tyr-573 is required for
CC       interaction with PTPN6/SHP-1. Phosphorylation of Tyr-571 is required
CC       for interaction with PTPN11/SHP-2. Phosphorylated tyrosine residues are
CC       important for interaction with specific binding partners.
CC       {ECO:0000269|PubMed:1714377, ECO:0000269|PubMed:7527401}.
CC   -!- DISEASE: Note=Defects in Kit are the cause of the white-spotting
CC       phenotype (W). White-spotting variants induces severe effects on
CC       pigmentation, gametogenesis and hematopoiesis. Mice homozygous for W42
CC       die perinatally of macrocytic anemia.
CC   -!- MISCELLANEOUS: Numerous proteins are phosphorylated in response to KIT
CC       signaling, but it is not evident to determine which are directly
CC       phosphorylated by KIT under in vivo conditions.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. CSF-1/PDGF receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y00864; CAA68772.1; -; mRNA.
DR   EMBL; AK046795; BAC32872.1; -; mRNA.
DR   EMBL; X65997; CAA46798.1; -; mRNA.
DR   EMBL; X65998; CAA46799.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; X65998; CAA46800.1; -; Genomic_DNA.
DR   EMBL; AY536430; AAS45606.1; -; mRNA.
DR   EMBL; AY536431; AAS45607.1; -; mRNA.
DR   EMBL; AC013622; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC115853; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC052457; AAH52457.1; -; mRNA.
DR   EMBL; BC075716; AAH75716.1; -; mRNA.
DR   EMBL; L11358; AAA37420.1; -; Genomic_DNA.
DR   CCDS; CCDS51525.1; -. [P05532-1]
DR   CCDS; CCDS80302.1; -. [P05532-2]
DR   PIR; A44876; A44876.
DR   PIR; S00474; TVMSKT.
DR   PIR; S24667; S24667.
DR   PIR; S34435; S34435.
DR   RefSeq; NP_001116205.1; NM_001122733.1. [P05532-1]
DR   RefSeq; NP_066922.2; NM_021099.3. [P05532-2]
DR   PDB; 2O26; X-ray; 2.50 A; U/W/X/Y=25-314.
DR   PDBsum; 2O26; -.
DR   AlphaFoldDB; P05532; -.
DR   SMR; P05532; -.
DR   BioGRID; 200957; 36.
DR   CORUM; P05532; -.
DR   DIP; DIP-59622N; -.
DR   IntAct; P05532; 5.
DR   MINT; P05532; -.
DR   STRING; 10090.ENSMUSP00000005815; -.
DR   BindingDB; P05532; -.
DR   ChEMBL; CHEMBL2034798; -.
DR   DrugCentral; P05532; -.
DR   GlyGen; P05532; 8 sites.
DR   iPTMnet; P05532; -.
DR   PhosphoSitePlus; P05532; -.
DR   MaxQB; P05532; -.
DR   PaxDb; P05532; -.
DR   PRIDE; P05532; -.
DR   ProteomicsDB; 263611; -. [P05532-1]
DR   ProteomicsDB; 263612; -. [P05532-2]
DR   ProteomicsDB; 263613; -. [P05532-3]
DR   ABCD; P05532; 1 sequenced antibody.
DR   Antibodypedia; 1392; 5458 antibodies from 57 providers.
DR   DNASU; 16590; -.
DR   Ensembl; ENSMUST00000005815; ENSMUSP00000005815; ENSMUSG00000005672. [P05532-1]
DR   Ensembl; ENSMUST00000144270; ENSMUSP00000116465; ENSMUSG00000005672. [P05532-2]
DR   GeneID; 16590; -.
DR   KEGG; mmu:16590; -.
DR   UCSC; uc008xug.2; mouse. [P05532-1]
DR   UCSC; uc012dxj.1; mouse. [P05532-2]
DR   CTD; 3815; -.
DR   MGI; MGI:96677; Kit.
DR   VEuPathDB; HostDB:ENSMUSG00000005672; -.
DR   eggNOG; KOG0200; Eukaryota.
DR   GeneTree; ENSGT00940000155626; -.
DR   HOGENOM; CLU_000288_49_0_1; -.
DR   InParanoid; P05532; -.
DR   OMA; KSSAYFN; -.
DR   OrthoDB; 236292at2759; -.
DR   TreeFam; TF325768; -.
DR   BRENDA; 2.7.10.1; 3474.
DR   Reactome; R-MMU-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-MMU-1433557; Signaling by SCF-KIT.
DR   Reactome; R-MMU-1433559; Regulation of KIT signaling.
DR   Reactome; R-MMU-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-MMU-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   BioGRID-ORCS; 16590; 1 hit in 75 CRISPR screens.
DR   ChiTaRS; Kit; mouse.
DR   EvolutionaryTrace; P05532; -.
DR   PRO; PR:P05532; -.
DR   Proteomes; UP000000589; Chromosome 5.
DR   RNAct; P05532; protein.
DR   Bgee; ENSMUSG00000005672; Expressed in cerebellum lobe and 304 other tissues.
DR   Genevisible; P05532; MM.
DR   GO; GO:0001669; C:acrosomal vesicle; ISO:MGI.
DR   GO; GO:0009986; C:cell surface; IDA:MGI.
DR   GO; GO:0005911; C:cell-cell junction; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; ISO:MGI.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0005615; C:extracellular space; ISO:MGI.
DR   GO; GO:0001650; C:fibrillar center; ISO:MGI.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019955; F:cytokine binding; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0002020; F:protease binding; IPI:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:MGI.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; ISO:MGI.
DR   GO; GO:0042169; F:SH2 domain binding; IPI:BHF-UCL.
DR   GO; GO:0005020; F:stem cell factor receptor activity; IDA:MGI.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; ISS:UniProtKB.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; ISS:UniProtKB.
DR   GO; GO:0030183; P:B cell differentiation; IBA:GO_Central.
DR   GO; GO:0060326; P:cell chemotaxis; ISS:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; TAS:MGI.
DR   GO; GO:0008283; P:cell population proliferation; IGI:MGI.
DR   GO; GO:0097067; P:cellular response to thyroid hormone stimulus; IDA:UniProtKB.
DR   GO; GO:0006935; P:chemotaxis; TAS:MGI.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IDA:MGI.
DR   GO; GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; IMP:UniProtKB.
DR   GO; GO:0048066; P:developmental pigmentation; IMP:MGI.
DR   GO; GO:0048565; P:digestive tract development; IMP:UniProtKB.
DR   GO; GO:0035234; P:ectopic germ cell programmed cell death; IMP:MGI.
DR   GO; GO:0035162; P:embryonic hemopoiesis; IMP:UniProtKB.
DR   GO; GO:0050673; P:epithelial cell proliferation; ISO:MGI.
DR   GO; GO:0030218; P:erythrocyte differentiation; IMP:UniProtKB.
DR   GO; GO:0038162; P:erythropoietin-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0038093; P:Fc receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007281; P:germ cell development; TAS:MGI.
DR   GO; GO:0008354; P:germ cell migration; ISO:MGI.
DR   GO; GO:0006687; P:glycosphingolipid metabolic process; IMP:MGI.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; IBA:GO_Central.
DR   GO; GO:0035701; P:hematopoietic stem cell migration; IMP:MGI.
DR   GO; GO:0030097; P:hemopoiesis; IMP:MGI.
DR   GO; GO:0002327; P:immature B cell differentiation; IMP:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IMP:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:MGI.
DR   GO; GO:0038109; P:Kit signaling pathway; ISO:MGI.
DR   GO; GO:0030032; P:lamellipodium assembly; IDA:UniProtKB.
DR   GO; GO:0002320; P:lymphoid progenitor cell differentiation; IGI:MGI.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:0002551; P:mast cell chemotaxis; ISO:MGI.
DR   GO; GO:0043303; P:mast cell degranulation; ISS:UniProtKB.
DR   GO; GO:0060374; P:mast cell differentiation; IMP:UniProtKB.
DR   GO; GO:0070662; P:mast cell proliferation; IGI:MGI.
DR   GO; GO:0035855; P:megakaryocyte development; IMP:UniProtKB.
DR   GO; GO:0097326; P:melanocyte adhesion; IDA:UniProtKB.
DR   GO; GO:0030318; P:melanocyte differentiation; IMP:UniProtKB.
DR   GO; GO:0097324; P:melanocyte migration; IMP:UniProtKB.
DR   GO; GO:0002318; P:myeloid progenitor cell differentiation; IGI:MGI.
DR   GO; GO:0051093; P:negative regulation of developmental process; IMP:MGI.
DR   GO; GO:0043069; P:negative regulation of programmed cell death; IMP:MGI.
DR   GO; GO:2000242; P:negative regulation of reproductive process; IMP:MGI.
DR   GO; GO:0001541; P:ovarian follicle development; IMP:UniProtKB.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:MGI.
DR   GO; GO:0043473; P:pigmentation; IMP:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISO:MGI.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:MGI.
DR   GO; GO:1904343; P:positive regulation of colon smooth muscle contraction; ISO:MGI.
DR   GO; GO:0002732; P:positive regulation of dendritic cell cytokine production; IMP:UniProtKB.
DR   GO; GO:0051091; P:positive regulation of DNA-binding transcription factor activity; ISO:MGI.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:MGI.
DR   GO; GO:0033674; P:positive regulation of kinase activity; IBA:GO_Central.
DR   GO; GO:0048170; P:positive regulation of long-term neuronal synaptic plasticity; ISO:MGI.
DR   GO; GO:0043406; P:positive regulation of MAP kinase activity; IGI:MGI.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISO:MGI.
DR   GO; GO:0032765; P:positive regulation of mast cell cytokine production; ISS:UniProtKB.
DR   GO; GO:0070668; P:positive regulation of mast cell proliferation; IGI:MGI.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; ISO:MGI.
DR   GO; GO:0031274; P:positive regulation of pseudopodium assembly; ISO:MGI.
DR   GO; GO:0120072; P:positive regulation of pyloric antrum smooth muscle contraction; ISO:MGI.
DR   GO; GO:0046427; P:positive regulation of receptor signaling pathway via JAK-STAT; ISO:MGI.
DR   GO; GO:1904349; P:positive regulation of small intestine smooth muscle contraction; ISO:MGI.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; ISO:MGI.
DR   GO; GO:1905065; P:positive regulation of vascular associated smooth muscle cell differentiation; ISO:MGI.
DR   GO; GO:0012501; P:programmed cell death; IGI:MGI.
DR   GO; GO:0046777; P:protein autophosphorylation; ISO:MGI.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:MGI.
DR   GO; GO:1904251; P:regulation of bile acid metabolic process; ISO:MGI.
DR   GO; GO:0008360; P:regulation of cell shape; IDA:UniProtKB.
DR   GO; GO:0046686; P:response to cadmium ion; IEA:Ensembl.
DR   GO; GO:0009314; P:response to radiation; IMP:MGI.
DR   GO; GO:0048103; P:somatic stem cell division; ISO:MGI.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; ISO:MGI.
DR   GO; GO:0007286; P:spermatid development; IMP:MGI.
DR   GO; GO:0007283; P:spermatogenesis; IMP:UniProtKB.
DR   GO; GO:0048863; P:stem cell differentiation; IMP:UniProtKB.
DR   GO; GO:0030217; P:T cell differentiation; IMP:UniProtKB.
DR   GO; GO:0043586; P:tongue development; IEA:Ensembl.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   GO; GO:0008542; P:visual learning; ISO:MGI.
DR   Gene3D; 2.60.40.10; -; 5.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013151; Immunoglobulin.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR027263; SCGF_receptor.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR001824; Tyr_kinase_rcpt_3_CS.
DR   Pfam; PF00047; ig; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   PIRSF; PIRSF500951; SCGF_recepter; 1.
DR   SMART; SM00409; IG; 4.
DR   SMART; SM00408; IGc2; 3.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF48726; SSF48726; 4.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00240; RECEPTOR_TYR_KIN_III; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell membrane; Cytoplasm;
KW   Disease variant; Disulfide bond; Glycoprotein; Immunoglobulin domain;
KW   Kinase; Magnesium; Membrane; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Proto-oncogene; Receptor; Reference proteome; Repeat;
KW   Signal; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase; Ubl conjugation.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   CHAIN           25..979
FT                   /note="Mast/stem cell growth factor receptor Kit"
FT                   /id="PRO_0000016755"
FT   TOPO_DOM        25..527
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        528..548
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        549..979
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          31..117
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          126..210
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          217..315
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          324..417
FT                   /note="Ig-like C2-type 4"
FT   DOMAIN          420..514
FT                   /note="Ig-like C2-type 5"
FT   DOMAIN          592..939
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          571..573
FT                   /note="Important for interaction with phosphotyrosine-
FT                   binding proteins"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        794
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         571
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   BINDING         599..606
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         626
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         674..680
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         798
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         799
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   BINDING         812
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   SITE            938
FT                   /note="Important for interaction with phosphotyrosine-
FT                   binding proteins"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         550
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P10721"
FT   MOD_RES         556
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P10721"
FT   MOD_RES         571
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:17947660"
FT   MOD_RES         573
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:17947660"
FT   MOD_RES         706
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:17947660"
FT   MOD_RES         720
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         723
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P10721"
FT   MOD_RES         732
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P10721"
FT   MOD_RES         743
FT                   /note="Phosphoserine; by PKC/PRKCA"
FT                   /evidence="ECO:0000250|UniProtKB:P10721"
FT   MOD_RES         748
FT                   /note="Phosphoserine; by PKC/PRKCA"
FT                   /evidence="ECO:0000250|UniProtKB:P10721"
FT   MOD_RES         823
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P10721"
FT   MOD_RES         825
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:7527401"
FT   MOD_RES         893
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P10721"
FT   MOD_RES         902
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P10721"
FT   MOD_RES         938
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:17947660"
FT   MOD_RES         962
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P10721"
FT   CARBOHYD        146
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        296
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:17255936"
FT   CARBOHYD        303
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:17255936"
FT   CARBOHYD        323
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        355
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        370
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        466
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        489
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        58..98
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:17255936"
FT   DISULFID        137..187
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:17255936"
FT   DISULFID        152..184
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:17255936"
FT   DISULFID        234..293
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:17255936"
FT   DISULFID        431..494
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         1..12
FT                   /note="MRGARGAWDLLC -> MAVAVFPFLPQQ (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:1378413"
FT                   /id="VSP_041868"
FT   VAR_SEQ         13..789
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:1378413"
FT                   /id="VSP_041869"
FT   VAR_SEQ         512..515
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:15731517, ECO:0000303|PubMed:2456920"
FT                   /id="VSP_041870"
FT   VARIANT         207
FT                   /note="A -> E (loss-of-function mutation abolishing ligand
FT                   binding)"
FT                   /evidence="ECO:0000269|PubMed:2456920, ECO:0000269|Ref.22"
FT   VARIANT         586
FT                   /note="E -> K (in W37 spotting; impaired protein stability
FT                   and loss of kinase activity)"
FT                   /evidence="ECO:0000269|PubMed:1693331,
FT                   ECO:0000269|PubMed:1714377"
FT   VARIANT         664
FT                   /note="T -> M (in Wv spotting)"
FT                   /evidence="ECO:0000269|PubMed:1693331"
FT   VARIANT         794
FT                   /note="D -> N (in W42 spotting; loss of kinase activity and
FT                   impaired internalization after exposure to KITLG/SCF)"
FT                   /evidence="ECO:0000269|PubMed:1688471,
FT                   ECO:0000269|PubMed:7527401"
FT   VARIANT         835
FT                   /note="V -> M (in W41 spotting; decreased kinase activity)"
FT                   /evidence="ECO:0000269|PubMed:1693331,
FT                   ECO:0000269|PubMed:1714377"
FT   MUTAGEN         571
FT                   /note="Y->F: Abolishes interaction with PTPN11/SHP-2."
FT                   /evidence="ECO:0000269|PubMed:9528781"
FT   MUTAGEN         573
FT                   /note="Y->F: Abolishes interaction with PTPN6/SHP-1."
FT                   /evidence="ECO:0000269|PubMed:9528781"
FT   MUTAGEN         573
FT                   /note="Missing: Abolishes interaction with PTPN6/SHP-1."
FT                   /evidence="ECO:0000269|PubMed:9528781"
FT   MUTAGEN         723
FT                   /note="Y->F: Abolishes interaction with PIK3R1."
FT                   /evidence="ECO:0000269|PubMed:7527401"
FT   MUTAGEN         860
FT                   /note="F->S: Mice display white fur, hearing loss, anemia
FT                   and mast cell deficiency, plus sterility in both males and
FT                   females."
FT                   /evidence="ECO:0000269|PubMed:15731517"
FT   CONFLICT        551
FT                   /note="L -> F (in Ref. 6; AAH52457)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        781
FT                   /note="G -> A (in Ref. 1; CAA68772 and 2; CAA46799)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        860
FT                   /note="F -> S (in Ref. 4; AAS45607)"
FT                   /evidence="ECO:0000305"
FT   STRAND          38..41
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          43..49
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          54..59
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          63..69
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          71..73
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          75..78
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          80..85
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   HELIX           90..92
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          94..103
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          105..113
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          125..128
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          133..135
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          145..151
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          162..166
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   TURN            167..169
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          170..175
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   HELIX           178..180
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          184..191
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          194..197
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          201..206
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          214..216
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          230..240
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          244..256
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          264..268
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          271..282
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          285..287
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          289..296
FT                   /evidence="ECO:0007829|PDB:2O26"
FT   STRAND          301..308
FT                   /evidence="ECO:0007829|PDB:2O26"
SQ   SEQUENCE   979 AA;  109343 MW;  03FB4D672248585E CRC64;
     MRGARGAWDL LCVLLVLLRG QTATSQPSAS PGEPSPPSIH PAQSELIVEA GDTLSLTCID
     PDFVRWTFKT YFNEMVENKK NEWIQEKAEA TRTGTYTCSN SNGLTSSIYV FVRDPAKLFL
     VGLPLFGKED SDALVRCPLT DPQVSNYSLI ECDGKSLPTD LTFVPNPKAG ITIKNVKRAY
     HRLCVRCAAQ RDGTWLHSDK FTLKVRAAIK AIPVVSVPET SHLLKKGDTF TVVCTIKDVS
     TSVNSMWLKM NPQPQHIAQV KHNSWHRGDF NYERQETLTI SSARVDDSGV FMCYANNTFG
     SANVTTTLKV VEKGFINISP VKNTTVFVTD GENVDLVVEY EAYPKPEHQQ WIYMNRTSAN
     KGKDYVKSDN KSNIRYVNQL RLTRLKGTEG GTYTFLVSNS DASASVTFNV YVNTKPEILT
     YDRLINGMLQ CVAEGFPEPT IDWYFCTGAE QRCTTPVSPV DVQVQNVSVS PFGKLVVQSS
     IDSSVFRHNG TVECKASNDV GKSSAFFNFA FKGNNKEQIQ AHTLFTPLLI GFVVAAGAMG
     IIVMVLTYKY LQKPMYEVQW KVVEEINGNN YVYIDPTQLP YDHKWEFPRN RLSFGKTLGA
     GAFGKVVEAT AYGLIKSDAA MTVAVKMLKP SAHLTEREAL MSELKVLSYL GNHMNIVNLL
     GACTVGGPTL VITEYCCYGD LLNFLRRKRD SFIFSKQEEQ AEAALYKNLL HSTEPSCDSS
     NEYMDMKPGV SYVVPTKTDK RRSARIDSYI ERDVTPAIME DDELALDLDD LLSFSYQVAK
     GMAFLASKNC IHRDLAARNI LLTHGRITKI CDFGLARDIR NDSNYVVKGN ARLPVKWMAP
     ESIFSCVYTF ESDVWSYGIF LWELFSLGSS PYPGMPVDSK FYKMIKEGFR MVSPEHAPAE
     MYDVMKTCWD ADPLKRPTFK QVVQLIEKQI SDSTKHIYSN LANCNPNPEN PVVVDHSVRV
     NSVGSSASST QPLLVHEDA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024